The Cambridge Healthtech Institute’s 13th Annual Liquid Biopsy meeting will explore the latest technologies in detection and molecular characterization of cancer tissue. Liquid biopsy is a maturing technology for early detection of disease, patient stratification and therapy selection, monitoring response to therapy, and detecting disease recurrence.
1. Medical 2. Research 3. Biotech 4. Education 5. Conferences
At Cambridge Healthtech Institute (CHI), we believe bringing together a unique and diverse constellation of innovators, scientists, and life science professionals can hold the key to developing tomorrow’s cures and diagnostics.